Remedent, Inc. (REMI)
USD 0.03
(-17.14%)
USD 0.03
(-17.14%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - USD | 0.0% |
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 5455.00 USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 1.13 Million USD | -22.11% |
| 2012 | 1.45 Million USD | 430.98% |
| 2011 | 273.55 Thousand USD | -35.77% |
| 2010 | 425.88 Thousand USD | 323.59% |
| 2009 | 100.54 Thousand USD | 6.11% |
| 2008 | 94.75 Thousand USD | -37.8% |
| 2007 | 152.34 Thousand USD | 149.75% |
| 2006 | 60.99 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | - USD | 0.0% |
| 2024 FY | - USD | 0.0% |
| 2024 Q3 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2021 Q3 | 5455.00 USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 5455.00 USD | 0.0% |
| 2021 Q1 | 5455.00 USD | 0.0% |
| 2020 Q2 | 86.83 Thousand USD | 0.0% |
| 2020 Q4 | 5455.00 USD | -93.72% |
| 2020 FY | 5455.00 USD | 0.0% |
| 2020 Q3 | 86.83 Thousand USD | 0.0% |
| 2020 Q1 | 86.83 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q1 | 1.13 Million USD | 0.0% |
| 2014 Q2 | 1.13 Million USD | 0.0% |
| 2014 Q3 | 131.36 Thousand USD | -88.39% |
| 2014 Q4 | - USD | -100.0% |
| 2014 FY | - USD | -100.0% |
| 2013 Q3 | 1.22 Million USD | 5.83% |
| 2013 Q2 | 1.16 Million USD | -17.73% |
| 2013 Q1 | 1.41 Million USD | -2.92% |
| 2013 FY | 1.13 Million USD | -22.11% |
| 2013 Q4 | 1.13 Million USD | -7.85% |
| 2012 FY | 1.45 Million USD | 430.98% |
| 2012 Q2 | 1.29 Million USD | 1.38% |
| 2012 Q3 | 1.3 Million USD | 0.98% |
| 2012 Q4 | 1.45 Million USD | 11.42% |
| 2012 Q1 | 1.27 Million USD | 365.55% |
| 2011 Q2 | 458.23 Thousand USD | 0.0% |
| 2011 FY | 273.55 Thousand USD | -35.77% |
| 2011 Q4 | 273.55 Thousand USD | -40.3% |
| 2011 Q3 | 458.23 Thousand USD | 0.0% |
| 2011 Q1 | 458.23 Thousand USD | 7.6% |
| 2010 FY | 425.88 Thousand USD | 323.59% |
| 2010 Q4 | 425.88 Thousand USD | 40.47% |
| 2010 Q1 | 100.54 Thousand USD | 0.0% |
| 2010 Q2 | 316.53 Thousand USD | 214.83% |
| 2010 Q3 | 303.17 Thousand USD | -4.22% |
| 2009 Q3 | 178.39 Thousand USD | 1.17% |
| 2009 FY | 100.54 Thousand USD | 6.11% |
| 2009 Q4 | 100.54 Thousand USD | -43.64% |
| 2009 Q2 | 176.32 Thousand USD | 4.58% |
| 2009 Q1 | 168.6 Thousand USD | 77.94% |
| 2008 Q3 | 149.71 Thousand USD | 0.92% |
| 2008 Q4 | 94.75 Thousand USD | -36.71% |
| 2008 Q2 | 148.35 Thousand USD | -3.87% |
| 2008 Q1 | 154.33 Thousand USD | 1.3% |
| 2008 FY | 94.75 Thousand USD | -37.8% |
| 2007 FY | 152.34 Thousand USD | 149.75% |
| 2007 Q4 | 152.34 Thousand USD | -21.27% |
| 2007 Q2 | 53.01 Thousand USD | -12.68% |
| 2007 Q3 | 193.5 Thousand USD | 265.02% |
| 2007 Q1 | 60.71 Thousand USD | -0.47% |
| 2006 Q3 | 63.35 Thousand USD | -6.9% |
| 2006 Q4 | 60.99 Thousand USD | -3.72% |
| 2006 Q2 | 68.04 Thousand USD | -5.77% |
| 2006 Q1 | 72.21 Thousand USD | 0.0% |
| 2006 FY | 60.99 Thousand USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | NaN% |
| Ansell Limited | 705.27 Million USD | 100.0% |
| Ansell Limited | 706.6 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 22.41 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | - USD | NaN% |
| Psykey, Inc. | 625 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
| Encision Inc. | 67.33 Thousand USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 382.83 Thousand USD | 100.0% |
| LifePoint, Inc. | 151.73 Thousand USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 849.37 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 100.0% |
| SheerVision, Inc. | - USD | NaN% |
| United Health Products, Inc. | 48.48 Thousand USD | 100.0% |
| Vasamed, Inc. | 18.95 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 390.44 Thousand USD | 100.0% |